In the meantime, the researchers have already sent their original 23-amino acid peptide to a research lab at the Icahn School of Medicine at Mount Sinai for testing in human cells and potentially in animal models of Covid-19 infection
The preclinical case is the broadest in its class a 2025 systematic review screened 544 articles across gut lining, tendon, muscle, blood vessel lining, and nerve tissue
Sikiric, et al, demonstrated its possible use to heal distended stomachs and noted that it has been used safely and with some effect in trials for irritable bowel disease
Using tissue from donors, the team observed that cells in the nucleus pulposus, a jelly-like structure at the center of intervertebral discs, had a lower amount of this peptide receptor when degeneration increased
Published large human clinical-trial data is not available, so consumer time to results framings sit outside the public regulatory evidence base